SARS-CoV-2 vaccine

BIOLOGICAL12 trials

Sponsors

Oslo University Hospital, Osman ERGANIS, PhD, Prof, Children's Hospital Medical Center, Cincinnati, The Second Affiliated Hospital of Chongqing Medical University, University Hospital, Caen

Conditions

Adverse Reaction to VaccineCOVID-19COVID-19 Humoral immunity, cell-mediated immunity, COVID-19, immunocompromisedChronic Kidney Disease Requiring Chronic DialysisCoronavirusCovid19Diseases, ChronicHIV Infection

Phase 1

Study of a Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Adjuvanted Inactivated Vaccine in Healthy Adults

TerminatedNCT04866069

Osman ERGANIS, PhD, ProfCovid19

Start: 2021-04-25End: 2021-09-05Updated: 2023-04-18

Phase 3

Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 Vaccine (SARS-CoV-2 [COVID-19] and Influenza) in Adults ≥50 Years of Age

CompletedNCT06694389

ModernaTX, Inc.COVID-19, Influenza

Start: 2024-11-18End: 2025-11-17Updated: 2025-12-02

Phase 4

SARS-CoV-2-specific immune responses after COVID-19 vaccination in solid organ transplant recipients

Active, not recruitingTCTR20210523002

Faculty of Medicine Ramathibodi HospitalCOVID-19 Humoral immunity, cell-mediated immunity, COVID-19, immunocompromised

Start: 2021-08-02Target: 250Updated: 2026-08-03

Unknown Phase

Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) Immune Kidney Transplant Study (COVID-19)

Active, not recruitingNCT04747522

Oslo University HospitalKidney Transplant Infection, SARS-CoV Infection

Start: 2021-01-22End: 2024-12-31Target: 150Updated: 2024-04-04

Antibody Detection of Vaccine-Induced Secretory Effects

CompletedNCT04895475

Children's Hospital Medical Center, CincinnatiCoronavirus, Covid19, Humoral Acquired Immunodeficiency +1

Start: 2021-02-19End: 2023-08-31Updated: 2025-07-30

Safety and Immune Response of COVID-19 Vaccination in Patients With Chronic Liver Diseases

The Second Affiliated Hospital of Chongqing Medical UniversityAdverse Reaction to Vaccine, Covid19, Liver Diseases

Start: 2021-07-01End: 2023-12-30Target: 2000Updated: 2021-08-16

Safety and Immune Response of COVID-19 Vaccination in Patients With Basic Disease

The Second Affiliated Hospital of Chongqing Medical UniversityAdverse Reaction to Vaccine, Covid19, Diseases, Chronic

Start: 2021-08-01End: 2023-08-01Target: 2300Updated: 2022-08-10

Safety and Immune Response of COVID-19 Vaccination in Overweight People With Excessive BMI

The Second Affiliated Hospital of Chongqing Medical UniversityCovid19, Overweight

Start: 2021-08-01End: 2022-08-01Target: 450Updated: 2021-09-14

COVID-19 Vaccines Associated Malaise

CompletedNCT05234333

University Hospital, CaenVaccine Adverse Reaction

Start: 2021-01-01End: 2022-01-26Updated: 2022-05-05

Humoral and Cellular Immunity Against SARS-COV-2 Vaccine in HIV-infected Patients Immunosuppressed

CompletedNCT05633927

Hospitales Universitarios Virgen del RocíoHIV Infection, SARS-CoV-2 RNA Vaccines

Start: 2021-04-01End: 2022-12-01Updated: 2024-10-15

Vaccine Responses in Cancer

Active, not recruitingNCT06605625

Abramson Cancer Center at Penn MedicineViral Vaccines

Start: 2022-11-04End: 2028-10-31Target: 250Updated: 2025-10-28

Impact Of Kidney Failure On The Regulation Of Humoral Response To Vaccination

RecruitingNCT06635525

Fondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoChronic Kidney Disease Requiring Chronic Dialysis, Vaccine Response

Start: 2024-10-16End: 2026-07-01Target: 146Updated: 2026-03-30

Related Papers

Immunogenicity, reactogenicity, and safety of an mRNA-based seasonal influenza and SARS-CoV-2 multicomponent vaccine, mRNA-1083, in adults aged ≥50 years in Japan.

2026-07-30

SARS-CoV-2-Specific Antibodies, B Cell and T Cell Immune Responses after ChAdOx1 nCoV-19 Vaccination in Solid Organ Transplant Recipients

Vaccines2024-05-15

Clinical characteristics and immunogenicity after Omicron breakthrough infection in patients with chronic hepatitis B infection: A longitudinal observational study

Journal of Medical Virology2024-03-01

Sustained and Boosted Antibody Responses in Breast Milk After Maternal SARS-CoV-2 Vaccination

Breastfeeding Medicine2023-08-013 citations

Humoral immune responses to inactivated COVID-19 vaccine up to 1 year in children with chronic hepatitis B infection

Frontiers in Cellular and Infection Microbiology2023-06-291 citations

The safety and immunogenicity of inactivated COVID-19 vaccine in old pulmonary tuberculosis patients

European Journal of Clinical Microbiology & Infectious Diseases2023-02-283 citations

Impaired antibody responses were observed in patients with type 2 diabetes mellitus after receiving the inactivated COVID-19 vaccines

Virology Journal2023-02-0718 citations

Safety and immunogenicity of inactivated COVID-19 vaccine in patients with metabolic syndrome: A cross-sectional observational study

Frontiers in Public Health2022-12-234 citations